{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:34:04Z","timestamp":1760834044744,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1054\/ctim.2000.0408","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:24Z","timestamp":1032432924000},"page":"12-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Iscador Qu for chronic hepatitis C: an exploratory study"],"prefix":"10.1054","volume":"9","author":[{"given":"K.J.","family":"Tusenius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Spoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.W.","family":"Kramers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/ctim.2000.0408_RF1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2893.1999.6120139.x","volume":"6","year":"1999","journal-title":"J Viral Hep"},{"key":"10.1054\/ctim.2000.0408_RF2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Hepatitis Interventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomised, controlled trial","volume":"321","author":"Davis","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1054\/ctim.2000.0408_RF3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0168-8278(91)90814-R","article-title":"Interferon for Non-A, Non-B chronic hepatitis. A meta-analysis of randomised clinical trials","volume":"13","author":"Tine","year":"1991","journal-title":"J Hepatol"},{"key":"10.1054\/ctim.2000.0408_RF4","first-page":"26","article-title":"Therapie Studie zur Hepatitis-C mit Abnoba Viscum und Solanum Lycopersicum","volume":"Sonderheft Juni","author":"Matthes","year":"1997","journal-title":"Merkurstab"},{"key":"10.1054\/ctim.2000.0408_RF5","first-page":"25","article-title":"Therapie der chronischen Hepatitis-B und -C","volume":"Sonderheft Juni","author":"Fintelman","year":"1997","journal-title":"Merkurstab"},{"key":"10.1054\/ctim.2000.0408_RF6","first-page":"1","article-title":"Mistletoe pharmacologically relevant components of viscum album","volume":"43 (suppl 1)","author":"Frantz","year":"1986","journal-title":"Oncology"},{"key":"10.1054\/ctim.2000.0408_RF7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0171-2985(85)80002-4","article-title":"The in vitro activity of lectin-1 from mistletoe (ML-1) and its isolated A and B chains on functions of macrophages and polymorphonuclear cells","volume":"169","author":"Metzner","year":"1985","journal-title":"Immunobiology"},{"key":"10.1054\/ctim.2000.0408_RF8","first-page":"4803","article-title":"Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients","volume":"49","author":"Hajto","year":"1989","journal-title":"Cancer Res"},{"key":"10.1054\/ctim.2000.0408_RF9","first-page":"3322","article-title":"Increased secretion of TNF-a, IL1, and IL6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract","volume":"50","author":"Hajto","year":"1990","journal-title":"Cancer Res"},{"key":"10.1054\/ctim.2000.0408_RF10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01741704","article-title":"A viscum album oligosaccharide activating human natural cyto toxicity is an interferon gamma inducer","volume":"32","author":"Mueller","year":"1990","journal-title":"Cancer Immunol. Immunotherapy"},{"key":"10.1054\/ctim.2000.0408_RF11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001813-199704001-00004","article-title":"Anti carcinogenic antimetastatic activity of Iscador","volume":"8(suppl 1)","author":"Kuttan","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1054\/ctim.2000.0408_RF12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00045391-199901000-00006","article-title":"Toxicity of a standarized Mistletoe Extract in Immunocompromised and healthy Individuals","volume":"6(1)","author":"Wely","year":"1999","journal-title":"Am J Therapeutics"},{"key":"10.1054\/ctim.2000.0408_RF13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0140-6736(93)90488-3","article-title":"Reliability of polymerase chain reaction for the detection of hepatitis C virus","volume":"341","author":"Zaaijer","year":"1993","journal-title":"Lancet"},{"key":"10.1054\/ctim.2000.0408_RF14","first-page":"905","article-title":"Quantitative determination of lectins in mistletoe preparations","volume":"45","author":"J\u00e4ggy","year":"1995","journal-title":"Arzneim Forsch"},{"key":"10.1054\/ctim.2000.0408_RF15","first-page":"210","article-title":"WHO recommendations for grading acute and subacute toxicity","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1054\/ctim.2000.0408_RF16","unstructured":"Measuring the quality of life of cancer patients with the RSCL. Groningen, Northern Centre for Healthcare Research (NCH), 1996"},{"key":"10.1054\/ctim.2000.0408_RF17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Shortform Health Survey (SF-36):1 Concepted framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1054\/ctim.2000.0408_RF18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1440-1746.1998.tb00714.x","article-title":"Relationships between serum aminotransferase levels, liver histologies and virological stutus in patients with chronic hepatitis C in Taiwan","volume":"13(7)","author":"Luo","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1054\/ctim.2000.0408_RF19","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1023\/A:1018852309885","article-title":"Effect of Interferon-\u03b1 Treatment of Chronic Hepatitis C on Health-Related Quality of Life","volume":"42(12)","author":"Hunt","year":"1997","journal-title":"Dige Dis Sc"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229900904084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229900904084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:54:51Z","timestamp":1760806491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229900904084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0965229900904084"],"URL":"https:\/\/doi.org\/10.1054\/ctim.2000.0408","relation":{},"ISSN":["0965-2299"],"issn-type":[{"type":"print","value":"0965-2299"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iscador Qu for chronic hepatitis C: an exploratory study","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1054\/ctim.2000.0408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}